AzTrials
AzTrials

Solid Tumor or LymphomaExPEDAJACNCT04711733

Supportive Care Needs of Former Child, AYA Cancer Patients, and of Their Parents: Evaluation During Long-term Follow-up

An observational study of Solid Tumor or Lymphoma, run by Centre Leon Berard at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Each year, there are 2100 new cases of cancer in children and adolescents/young adults (AYA) in France. Due to a significant improvement in the effectiveness of therapies, the survival rate of all types of cancer combined after 5 years is 80-85%. Read more about this study

Who is it for?
Ages 6 to 31 years
Conditions the study is for
Solid Tumor or Lymphoma
What is being tested?
Interview, Self-report questionnaire and Medical consultation
How many people
99 participants
Where
1 siteFrance
Study dates
11 Feb 2021to 15 Feb 2023
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 6 to 31 years
  • All sexes
  • No healthy volunteers
  • Child, Adult

Study population: The study will be proposed systematically to all former patients of the hospital department diagnosed before the age of 25 years and at least 6 years of age at the time of inclusion as well as to their parents. The experiences and the specific needs of each person (patients, mothers and fathers) will be assessed independently. Three independent groups will be formed based on the age of the patient when included in the study. For each group, the parents may or may not be paired with the patients. A sample of 60 former pediatric patients (20 per age group) and 60-120 parents (ideally 40 per age group) is expected. This is the number of interviews after which data saturation generally occurs, i.e. no emergence of new themes from one interview to another.

Who may be able to join

  • Age of the patient or the parent of a patient aged ≤ 25 years at diagnosis and at least 6 years of age at the time of inclusion
  • Patient, or the parent of a patient, previously treated at Institut d'Hématologie et d'Oncologie Pédiatrique /Leon Berard comprehensive cancer centre
  • Patient treated for a solid tumor or a lymphoma
  • Patient in complete response and having finished his/her standard oncological monitoring between 1 and 6 months ago i.e. 3 to 5 years after the diagnosis
  • Patients and parents capable of understanding, reading and writing French
  • Patient affiliated to a health insurance plan
  • Having been informed of the study and not objecting to it

Who cannot join

  • Cannot be followed-up for medical, social, familial, geographical or psychological reasons, throughout the duration of the study
  • Deprived of liberty by a court or administrative decision
  • Person who refused to participate or was incapable of objecting in an informed manner

Trial locations and contacts

1 site in 1 country.

France1 site
  • Centre Léon Bérard - Institut d'Hémato-Oncologie Pediatrique

    Lyon, 69373

Other trials in France

About this study

Official title: Supportive Care Needs of Former Child, Adolescent and Young Adult Cancer Patients, and of Their Parents: Evaluation During Long-term Follow-up

Each year, there are 2100 new cases of cancer in children and adolescents/young adults (AYA) in France. Due to a significant improvement in the effectiveness of therapies, the survival rate of all types of cancer combined after 5 years is 80-85%. This is leading to the emergence of new problems, which require an adaptation of the long-term care of these former patients. Nevertheless, although some medical complications have been widely described and are the subject of recommendations, many questions remain unanswered regarding the real long-term needs of patients and of their main caregivers.

The main objective of this study is to assess not only the specific supportive care needs of former onco-hematology patients treated before the age of 25 years, but also those of their parents up to 6 months after the end of the oncological follow-up, i.e. 3 to 5 years after the diagnosis.

Read more

The secondary objectives aim to:

  1. Assess adherence to long-term follow-up medical consultation
  2. Assess the early complications presented by the patients
  3. Assess the quality of life and the anxiety-depression of former patients and their parents
  4. Describe and evaluate the offer and use of the network of health professionals aware of the post-treatment issues; assess the referral to the network of health professionals aware of the post-treatment issues.

Depending on the objectives, the methodology used in this study is mixed, qualitative and quantitative. The study will be proposed systematically to all former patients of the hospital department diagnosed before the age of 25 years and at least 6 years of age at the time of inclusion as well as to their parents. A sample of 60 former pediatric patients (20 per age group) and 60-120 parents (ideally 40 per age group) is expected.

At the scientific level, this study will provide a better understanding of the cognitive and emotional processes involved in the long-term follow-up, in particular by identifying the supportive care needs of different participants (former patients and parents) and their experiences and quality of life during the long-term follow-up phase. At the individual level, this pilot study will enable the development of a multiprofessional structure, expert in cancer after-care from the end of the oncological follow-up.

Read the detailed description

Rational Each year, there are 2100 new cases of cancer in children and adolescents/young adults (AYA) in France. Due to a significant improvement in the effectiveness of therapies, the survival rate of all types of cancer combined after 5 years is 80-85%. This is leading to the emergence of new problems, which require an adaptation of the long-term care of these former patients. Many studies highlight that 60 to 65% of pediatric oncology patients will present medical and/or psychosocial complications in the 20 years following their oncological treatment, with a cumulative incidence of a serious adverse event of 40% 30 years after the cancer diagnosis. Nevertheless, although some medical complications have been widely described and are the subject of recommendations, many questions remain unanswered regarding the real long-term needs of patients and of their main caregivers, in this project their parents. It is therefore necessary to identify the risk factors by determining the expectations and the supportive care needs of patients and their caregivers in the long-term follow-up in order to intervene early and thus reduce the incidence of these later complications.

However, only 30 to 50% of former patients in pediatric oncology-hematology and their family attend a long-term follow-up medical consultation. We hypothesize that this lack of commitment is multifactorial (e.g. unmet supportive care needs, geographical distance from home, lack of information about the importance of long-term follow-up and follow-up structures nearby) and that a precise study of the needs expressed by former patients and their family should lead to an improved attendance at these consultations.

A better understanding of the supportive care needs of these patients and their families, as well as the brakes/obstacles or lers of their compliance with a long-term follow-up, is therefore essential to improve their quality of life, prevent or detect the sequela of therapies and reduce the risk of morbidity/mortality.

Objectives The main objective of this study is to assess not only the specific supportive care needs of former onco-hematology patients treated before the age of 25 years, but also those of their parents up to 6 months after the end of the oncological follow-up, i.e. 3 to 5 years after the diagnosis.

The secondary objectives aim to:

  1. Assess adherence to long-term follow-up medical consultation
  2. Assess the early complications presented by the patients
  3. Assess the quality of life and the anxiety-depression of former patients and their parents
  4. Describe and evaluate the offer and use of the network of health professionals aware of the post-treatment issues; assess the referral to the network of health professionals aware of the post-treatment issues.

Methodology Depending on the objectives, the methodology used in this study is mixed, qualitative and quantitative. The study will be proposed systematically to all former patients of the hospital department diagnosed before the age of 25 years and at least 6 years of age at the time of inclusion as well as to their parents. The experiences and the specific needs of each person (patients, mothers and fathers) will be assessed independently. Three independent groups will be formed based on the age of the patient when included in the study. For each group, the parents may or may not be paired with the patients. A sample of 60 former pediatric patients (20 per age group) and 60-120 parents (ideally 40 per age group) is expected.

Expected results At the scientific level, this study will provide a better understanding of the cognitive and emotional processes involved in the long-term follow-up, in particular by identifying the supportive care needs of different participants (former patients and parents) and their experiences and quality of life during the long-term follow-up phase. This first stage will be followed by more powerful studies on the modalities of following-up patients after cancer, in order to add to previously published research on the long-term medical and psychological side effects.

At the individual level, this pilot study will enable the development of a multiprofessional structure, expert in cancer after-care from the end of the oncological follow-up. This support could be initiated early and the link with the local network established quickly. It should reduce the experience of being abandoned presented by former patients and their families. At the family level, studying the needs expressed by parents could lead to a family psychological approach in order to restore the family links impacted by the disease.

At the organizational level, this study should serve as a basis for developing a structure that can carry out tertiary prevention, and thus reduce the costs attributable to long-term side effects (e.g. educational and professional absenteeism, use of treatments, private consultations or even hospitalization).

Being tested
Interview, Self-report questionnaire, Medical consultation
Keywords
Psycho-oncology, Health Psychology, Paediatric oncology, Supportive care, Survivorship, Caregiver, Children, Adolescents and Young Adults
Medical subject headings
Lymphoma

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • InterviewOther

    The qualitative interview aims to identify the supportive care needs of patients and parents as well as their expectations with regard to a long-term follow-up.

  • Self-report questionnaireOther

    To assess the quality of life, anxiety/depression of former patients and relatives:

    For child and adolescent patients (less than 15 years old at inclusion):

    • Pediatric Quality of Life Inventory Cancer module
    • Screen for Child Anxiety Related Emotional Disorders Revised
    • Children's Depression Inventory

    For patients over 15 years of age at the time of inclusion and parents:

    • 36-Item Short Form Health Survey
    • Hospital Anxiety and Depression Scale

    To describe and evaluate the offer and use of the network of health professionals who are aware of post-treatment issues: number of consultations, speciality and location of the professionals requested following the long-term follow-up consultation, time between referral and first consultation, evaluation of the geographical accessibility of care around the patient's home.

  • Medical consultationOther

    To assess adherence to long-term follow-up medical consultation:

    • number of patients summoned/ number of consultations carried out ; reason for refusal of long-term follow-up medical consultation To assess medical complications through clinical data collection
Study groups in NCT04711733
Study groupRoleWhat they receive
Patients 6-14 years oldIndividual interview + Self-report questionnaire + long-term follow-up medical consultation + At 1 year : Assessment of prescription's adherence
Receives: Other: Interview; Other: Self-report questionnaire; Other: Medical consultation
Parents of 6-14 years old patientsIndividual interview + Self-report questionnaire
Receives: Other: Interview; Other: Self-report questionnaire
Patients 15-25 years oldIndividual interview + Self-report questionnaire + long-term follow-up medical consultation + At 1 year : Assessment of prescription's adherence
Receives: Other: Interview; Other: Self-report questionnaire; Other: Medical consultation
Parents of 15-25 years old patientsIndividual interview + Self-report questionnaire
Receives: Other: Interview; Other: Self-report questionnaire
Patients > 25 years oldIndividual interview + Self-report questionnaire + long-term follow-up medical consultation + At 1 year : Assessment of prescription's adherence
Receives: Other: Interview; Other: Self-report questionnaire; Other: Medical consultation
Parents of > 25 years old patientsIndividual interview + Self-report questionnaire
Receives: Other: Interview; Other: Self-report questionnaire

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Qualitative interview

    To identify the supportive care needs of patients and parents as well as their expectations with regard to a long-term follow-up

    Measured: From 1 to 6 months after the standard monitoring consultation

Secondary outcomes (5)
  1. Quantitative measures to assess adherence to long-term follow-up medical consultation

    Number of patients summoned/ number of consultations carried out ; reason for refusal of long-term follow-up medical consultation

    Measured: From 1 to 6 months after the standard monitoring consultation

  2. Clinical Case Report Form to assess the early complications presented by the patients

    Clinical data : cardiac/renal/bones/digestive/hepatic/endocrine/dermatological/sexual/pulmonary/nutritional damages, pain, physical activity, addictology, tiredness, psychological follow-up

    Measured: From 1 to 6 months after the standard monitoring consultation

  3. Scores of quality of life

    For child and adolescent patients (less than 15 years old at inclusion):

    • Pediatric Quality of Life Inventory Cancer module

    For patients over 15 years of age at the time of inclusion and parents:

    • 36-Item Short Form Health Survey

    Measured: From 1 to 6 months after the standard monitoring consultation

  4. Scores of anxiety-depression

    For child and adolescent patients (less than 15 years old at inclusion):

    • Screen for Child Anxiety Related Emotional Disorders Revised
    • Children's Depression Inventory

    For patients over 15 years of age at the time of inclusion and parents:

    • Hospital Anxiety and Depression Scale

    Measured: From 1 to 6 months after the standard monitoring consultation

  5. Quantitative measures to describe and evaluate the offer and use of the network of health professionals who are aware of post-treatment issues

    number of consultations, speciality and location of the professionals requested following the long-term follow-up consultation, time between referral and first consultation, evaluation of the geographical accessibility of care around the patient's home

    Measured: One year after the long-term follow-up consultation

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Jan 2021
  2. Study start11 Feb 2021
  3. Primary completion18 Jan 2023
  4. Study completion15 Feb 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Prospective
Enrolment
99 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04711733
Sponsor's protocol ID
ET20000319
Acronym
ExPEDAJAC
Status last verified
Mar 2025
First submitted
11 Jan 2021
Last updated
5 Mar 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Solid Tumor or Lymphoma, run by Centre Leon Berard at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 5 Mar 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Qualitative interview (time frame: From 1 to 6 months after the standard monitoring consultation). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Mar 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in